Topics

U.S. FDA approves Celgene's rare blood disorder drug

08:09 EST 8 Nov 2019 | Reuters

The U.S. Food and Drug Administration said on Friday it had approved a treatment for a rare blood disorder from Celgene Corp, which is in the process of being bought by Bristol-Myers Squibb Co.

Original Article: U.S. FDA approves Celgene's rare blood disorder drug

NEXT ARTICLE

More From BioPortfolio on "U.S. FDA approves Celgene's rare blood disorder drug"

Quick Search

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...